Fabtech Technologies International

In 2015, 14 million people died from infectious diseases, most of them preventable or treatable. The WHO estimates there will be over 13 million deaths from infectious diseases in 2050. Despite medical advancements, people will continue to die needlessly. Treatable and preventable diseases affect the poorest among us. Our purpose is deeply rooted in our belief that all lives have equal value. Together with our customers and partners, we’re building pharmaceutical and biotech capability, so everyone, wherever they are in the world has the same access to affordable life-saving medicines. We are an engineering solutions company, a small but essential piece of the massive life sciences ecosystem. By bringing together our customers, partners, industry thought leaders, regulators and governments we effect greater impact and bring our mission to life. Our purpose is reflected in our strategy, our approach and our objectives. We consciously evaluate our performance through a broader lens with the 3BL (Triple Bottom Line) approach to creating value – economic benefits to our customers, environmental benefits for a greener planet and social benefits to people everywhere.